Garza-Morales, R.; Gonzalez-Ramos, R.; Chiba, A.; Montes de Oca-Luna, R.; McNally, L.R.; McMasters, K.M.; Gomez-Gutierrez, J.G.
Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro. Cancers 2018, 10, 144.
https://doi.org/10.3390/cancers10050144
AMA Style
Garza-Morales R, Gonzalez-Ramos R, Chiba A, Montes de Oca-Luna R, McNally LR, McMasters KM, Gomez-Gutierrez JG.
Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro. Cancers. 2018; 10(5):144.
https://doi.org/10.3390/cancers10050144
Chicago/Turabian Style
Garza-Morales, Rodolfo, Roxana Gonzalez-Ramos, Akiko Chiba, Roberto Montes de Oca-Luna, Lacey R. McNally, Kelly M. McMasters, and Jorge G. Gomez-Gutierrez.
2018. "Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro" Cancers 10, no. 5: 144.
https://doi.org/10.3390/cancers10050144
APA Style
Garza-Morales, R., Gonzalez-Ramos, R., Chiba, A., Montes de Oca-Luna, R., McNally, L. R., McMasters, K. M., & Gomez-Gutierrez, J. G.
(2018). Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro. Cancers, 10(5), 144.
https://doi.org/10.3390/cancers10050144